A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1997
12/30/1997	CA2060833C Analgesic composition containing ibuprofen
12/29/1997	EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics
12/29/1997	EP0814087A2 Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans
12/29/1997	EP0814080A1 Squalene synthetase inhibitors
12/29/1997	EP0813870A1 Use of darifenacin to enhance cognitive functions
12/29/1997	EP0813545A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
12/29/1997	EP0813544A1 Bradykinin antagonist peptides incorporating n-substituted glycines
12/29/1997	EP0813532A1 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO- a,d]CYCLOHEPTEN-5,10-IMINES BY OPTICAL RESOLUTION
12/29/1997	EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity
12/29/1997	EP0813524A1 Indole derivatives as eaa antagonists
12/29/1997	EP0813420A1 Treatment of cerebral ischemia and cerebral damage with neuroprotective agent
12/29/1997	EP0813416A1 Reduction of infarct volume using citicoline
12/29/1997	EP0719264B1 Imidazolone and oxazolone derivatives as dopamine antagonists
12/29/1997	EP0656775B1 Sustained release tablets containing bupropion
12/26/1997	CA2208652A1 Pharmaceutical compounds
12/24/1997	WO1997048792A1 Transgenic non-human mammals with progressive neurologic disease
12/24/1997	WO1997048724A2 Human metabotropic glutamate receptor
12/24/1997	WO1997048701A1 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors
12/24/1997	WO1997048699A1 Indoline derivatives useful as 5-ht-2c receptor antagonists
12/24/1997	WO1997048697A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
12/24/1997	WO1997048691A1 Ring-fused dihydropyranes, process for the preparation and use thereof
12/24/1997	WO1997048681A1 Sulphonamide derivatives and their use in the treatment of cns disorders
12/24/1997	WO1997048680A1 Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use
12/24/1997	WO1997042941A3 Buccal delivery system
12/24/1997	WO1997036588A3 Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain
12/24/1997	CN1168699A Protein kinase NPK-llo
12/24/1997	CN1168672A 2,7-substituierte octahydro-1H-pyrido £1,2-A\| pyrazin derivate
12/24/1997	CN1168670A 1,2,3,4-tetrahydroquinoxalindione derivative
12/24/1997	CN1168377A Novel buprenophine analgesic analogues
12/24/1997	CN1036779C Aryl naphthenes derivant and its use
12/24/1997	CA2258919A1 Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use
12/24/1997	CA2258247A1 Sulphonamide derivatives and their use in the treatment of cns disorders
12/24/1997	CA2258240A1 Indoline derivatives useful as 5-ht-2c receptor antagonists
12/24/1997	CA2246751A1 Human metabotropic glutamate receptor
12/23/1997	US5700948 Pyrrolidine compounds and process of preparing
12/23/1997	US5700947 Having reduced side effects
12/23/1997	US5700924 Serpin derived from human hypothalamus
12/23/1997	US5700911 Bone morphogenetic protein -11 (BMP-11) compositions
12/23/1997	US5700909 For stimulating neural cell outgrowth
12/23/1997	US5700827 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds
12/23/1997	US5700818 Serotonin antagonists for treatment of nervous system, brain or psychological disorders
12/23/1997	US5700816 Antiarthritic agents
12/23/1997	US5700813 Treatment of thrombotic illness
12/23/1997	US5700812 Antispasmodic agent for cardiovascular disorder, antiserotonine agent
12/23/1997	US5700808 5- or 6-substituted β-carboline-3-carboxylic acid esters
12/23/1997	US5700779 Bradykinin antagonist peptides incorporating N-substituted glycines
12/23/1997	CA2178637C Paroxetine tablets and process to prepare them
12/23/1997	CA2126972C Styrene derivative and salts thereof
12/23/1997	CA2008391C 1,2-cyclohexylaminoaryl amides useful as analgesic agents
12/20/1997	CA2208174A1 Squalene synthetase inhibitors
12/18/1997	WO1997047744A2 T-cell selective interleukin-4 agonists
12/18/1997	WO1997047619A1 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
12/18/1997	WO1997047602A1 Tricyclic amine derivatives
12/18/1997	WO1997047304A1 Fast-dissolving galanthamine hydrobromide tablet
12/18/1997	WO1997047302A1 Inhibition of serotonin reuptake
12/18/1997	CA2256649A1 Inhibition of serotonin reuptake
12/18/1997	CA2256459A1 T-cell selective interleukin-4 agonists
12/17/1997	EP0812831A1 Benzimidazole derivatives and their use as corticotropin releasing factor antagonists
12/17/1997	EP0812826A1 1H-indole and benzo(b)thiophene derivatives with 4-(1,2,3,6-tetra:hydro:pyridinyl)- and 4-piperidinyl-groups bound to the heterocyclic ring as inhibitors of serotonin reuptake
12/17/1997	EP0812591A1 Injectable compositions containing Nimesulide
12/17/1997	EP0812587A1 Transdermal compositions containing Nimesulide
12/17/1997	EP0812318A1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds
12/17/1997	EP0812208A1 Pharmaceutical compositions for controlled release of soluble receptors
12/17/1997	EP0812190A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof
12/17/1997	EP0698025B1 Ampa antagonists and a method of treatment therewith
12/17/1997	EP0644762B1 Pyrazolopyridine compounds for the treatment of anemia
12/17/1997	EP0533804B1 Sigma binding site agents
12/17/1997	CN1168140A Hydroxymethyl imidazodiazepines and their esters
12/17/1997	CN1168138A Aryl and heteroaryl purine compounds
12/17/1997	CN1168101A Use of 3,4-diphenyl chromans for manufacture of pharmaceutical composition for treatment or prophylaxis of cerebral degenerative disorders
12/17/1997	CN1168095A Treatment of attention-deficit/hyperactivity disorder
12/17/1997	CN1167762A Tetrahydroisoquinoline derivatives and their use
12/17/1997	CN1167617A Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
12/16/1997	US5698594 Treatment and prevention of risk factors for cardiovascular diseases
12/16/1997	US5698588 Optically pure enantiomeric form; treating central nervous system disorders
12/16/1997	US5698581 Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
12/16/1997	US5698578 Protein kinase C inhibitors
12/16/1997	US5698573 Imidazolone and oxazolone derivatives as dopamine antagonists
12/16/1997	US5698571 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
12/16/1997	US5698568 Substance p antagonists
12/16/1997	US5698555 Hetaryloxy-β-carbolines, their production and use in pharmaceutical agents
12/16/1997	US5698553 Nervous system disorders
12/16/1997	US5698551 Treatment of diabetic neuropathy, migraines, neurogenic inflammation, rheumatic arthritis and insulin resistance
12/16/1997	US5698517 Thyroxin-binding HSA fragments
12/16/1997	US5698445 Human PAK65
12/16/1997	US5698428 Human PAK65
12/16/1997	US5698221 Containing 2-amino-2-(4-methylpiperazin-1-ylzzzz0-5-(2,3,5-trichlorophen yl)pyrimidine
12/16/1997	US5698216 Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof
12/16/1997	CA2168829C Paroxetine hydrochloride anhydrate forms a,b,c and d
12/16/1997	CA2086432C 3-(1-substitutedpyrazoyl)-2-oxindole derivatives
12/16/1997	CA1339584C 2-substituted ergolines, their production and use
12/13/1997	CA2206219A1 A novel process for the manufacture of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo [1,5a] [1,4] benzodiazepine (midazolam)
12/13/1997	CA2206192A1 Modulation of lc132 (opioid-like) receptor function
12/11/1997	WO1997046671A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	WO1997046579A1 Neuropeptide y agonists
12/11/1997	WO1997046565A1 SELECTED DERIVATIVES OF K-252a
12/11/1997	WO1997046556A1 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
12/11/1997	WO1997046554A1 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
12/11/1997	WO1997046527A1 Polymorphs of donepezil hydrochloride and process for production
12/11/1997	WO1997046526A1 Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production

1 ... 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 ... 1833